データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
101861-63-6O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12KNBSYZNKEAWABY-UHFFFAOYSA-N101861-63-6、130798-51-5DTXSID901356859CHEMBL31344安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明NMDA receptors are neuroreceptors that have binding sites for glycine or D-serine as well as L-glutamate. MDL 29951 is an antagonist of NMDA receptors with high affinity for the glycine binding site (Ki = 140 nM). It is functional both in vitro and in vivo. MDL 29951 blocks NMDA receptor-dependent convulsions in audiogenic seizure-susceptible DBA/2J mice. It is used to evaluate the role of the glycine site of the NMDA receptor in neurological signaling. MDL 29951 is also an agonist of the G protein-coupled receptor GPR17 (EC50 values range from 7 nM to 6 μM, depending on the assay). GPR17 is thought to be involved in oligodendrocyte differentiation and myelin formation/repair.
使用MDL 29951 is an allosteric inhibitor of the enzyme fructose 1,6-bisphosphatase.
現在のフィルター条件では反応記録がありません。
読み込み中…